Financials
- Market Capitalization 1.77 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.15
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2076 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.38 USD | +1.20% | -7.40% | +3.36% | -36.11% | 1.79 B USD | ||
| 2077 | PGEN Precigen, Inc. - Common Stock | 5.11 USD | -0.20% | -6.75% | +6.24% | +174.73% | 1.82 B USD | ||
| 2117 | IMCR Immunocore Holdings plc - American Depositary Shares | 33.43 USD | -0.12% | +1.18% | +16.85% | -0.15% | 1.70 B USD | ||
| 2120 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 6.75 USD | +3.69% | +18.42% | +36.09% | +158.62% | 1.74 B USD |